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Abstract
Background
Possession of the ε4 allele of the Apolipoprotein E (APOE) gene is associated with an
increased risk of Alzheimer’s disease. Early adult life effects of ε4 are less well understood.
Working memory has been relatively little studied (compared to episodic memory) in relation
to APOE genotype despite its importance in cognitive functioning. Our hypothesis was that
ε4 would lead to an impairment in working memory in young adults.
Methods
We studied working memory using a computerised n-back task in the Avon Longitudinal
Study of Parents and Children (ALSPAC) at age 18. Data was available for 1049–1927 par-
ticipants and for the 2- and 3-back versions of the task. Using multiple and multi-level
regression controlling for important confounders we examined the association between
APOE genotype on accuracy and reaction times.
Results
There was no evidence of a genotype effect on accuracy when the two difficulty levels were
examined separately. There was some evidence to support a deleterious effect of the ε4
allele on n-back accuracy in the multi-level regression. There was weak evidence that the
ε22 group were less accurate but the numbers were very low in this group. The ε34 group
had faster reaction times than the reference ε33 group in all adjusted analyses but the ε44
group were only faster in the 3-back condition in multi-level analyses.
Conclusions
There was no evidence of benefit in ε4 carriers, but there was some evidence of a detrimen-
tal effect on working memory in this large study.
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Introduction
APOE is a gene found on chromosome 19 in humans, which encodes a protein (ApoE) involved
in lipid transport. ApoE is the main lipid transport protein in the brain. There are 3 known vari-
ants of APOE: ε2, ε3 and ε4. E4 is thought to be the ancestral allele of APOE, [1] but in the UK
population the reported frequencies of ε3, ε4 and ε2 are 0.78, 0.14 and 0.08 respectively.[2]
These variants result from single nucleotide polymorphisms at two locations: T2060C
(Cys112Arg) and C2198T (Arg158Cys).[3] The ε3 allele has cysteine and arginine in these two
positions, the ε2 allele has cysteine in both and the ε4 allele has arginine in both.[4] Individuals
carry two copies of APOE and thus may be heterozygous or homozygous (e.g. ε33, ε34).
Possession of an ε4 allele leads to an increased risk of late onset Alzheimer's disease (LOAD). [5]
One ε4 allele confers a threefold increase in risk and possession of two ε4 alleles confers a tenfold
increase in risk.[6] It is now known that ApoE is involved in neuronal repair, with E4 being the
least efficient isoform [7] and that APOE genotype influences outcome following head injury.[8]
Although episodic memory is the major cognitive process affected early in LOAD, it is not
the only process affected early in the the disease process.[9] Poor working memory perfor-
mance has been reported as one of the earliest deficits seen in Alzheimer's disease.[10] Deficits
in working memory have also been demonstrated in mild cognitive impairment, considered to
be a prodrome for LOAD.[11] There are several different types of working memory, for exam-
ple spatial and verbal. These are also thought to have separate storage and maintenance pro-
cesses.[12] Different working memory tasks measure different aspects of working memory,
which can make it difficult to compare studies.
The relationship between working memory and ε4 has been relatively little studied. There
are suggestions from the quantitative results of a RVIP (rapid visual information processing)
task reported in a small fMRI study of 41 young adults that ε4 may be beneficial for attention
but there was no adjustment for confounding factors. [13] Conversely studies of middle aged
and older adults have found a deleterious effect of ε4 on working memory. [14–16] A study of
445 people of mixed ages found no evidence for an effect. [17]
The possibility of the ε4 allele having positive effects earlier in life (positive pleiotropy) has
been investigated over the last 10 years with mixed results (e.g. [18, 19]). There is no associa-
tion between ε4 and IQ at age 8 years [20], but ε4 allele posession has been shown to have a
deleterious effect on IQ at age 80 including in non-demented participants.[21] Several fMRI
studies have reported reduced hippocampal activation in young adult e4 carriers. [22–24] For
example, Mondadori and colleagues found in an fMRI study of 34 subjects that those with the
ε34 genotype decreased their hippocampal activation with increasing number of trials of an
episodic memory task, whereas those with ε32 and ε33 increased their activation. They sug-
gested that this reflected more efficient learning in ε34 carriers, arguing that those with the ε34
genotype required less hippocampal activation for the same memory performance.
In this study we aimed to study the relationship between APOE genotype and working
memory assessed using the n-back working memory task in a large community sample of
young adults aged 18 years. We hypothesised that APOE genotype would be associated with
working memory performance, with the worst performance being in ε4 carriers in a dose
dependent manner due to its lower efficiency in neuronal repair.
The Avon Longitudinal Study of Parents and Children (ALSPAC) (http://www.bristol.ac.
uk/alspac) is a prospective study which was set up in 1991. [25–27] This large sample permitted
the inclusion of many more ε4 and ε2 homozygotes than in previous studies. No previous
study has included more than 500 participants and all have had small numbers of ε44 homozy-
gotes. For example, in the study by Reinvang and colleagues there were only 13 participants
with an ε44 genotype.[14]
APOE andWorking Memory
PLOS ONE | DOI:10.1371/journal.pone.0135894 August 19, 2015 2 / 13
Funding: This publication was supported by the
Wellcome Trust (084268/Z/07/Z). LS is supported by
a research training fellowship from the Wellcome
Trust (096114/Z/11/Z). MRM is a member of the UK
Centre for Tobacco Control Studies, a UKCRC Public
Health Research: Centre of Excellence. Funding from
British Heart Foundation, Cancer Research UK,
Economic and Social Research Council, Medical
Research Council, and the National Institute for
Health Research, under the auspices of the UK
Clinical Research Collaboration, is gratefully
acknowledged. KSB is funded by the National
Institute for Health Research School for Primary Care
Research (NIHR SPCR). The NIHR SPCR is a
partnership between the Universities of Birmingham,
Bristol, Keele, Manchester, Nottingham, Oxford,
Southampton and University College London. The
funders had no role in the study design, data
collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interets exist.
Methods & Materials
Sample
The Avon Longitudinal Study of Parents and Children (ALSPAC) (http://www.bristol.ac.uk/
alspac) is a prospective study which was set up in 1991. [25–27] All pregnant women in the for-
mer Avon area with an expected date of delivery between April 1991 and December 1992 were
eligible for inclusion. Recruitment was via a wide range of methods. In total 14,541 women
were enrolled, resulting in 14,062 live births and 13,988 children alive at one year. For reasons
of confidentiality data on the 13 triplet and quadruplet children were not available for analysis.
At age 7, a further 548 eligible children and after age 8 a further 452 children were added to the
sample when their mother enrolled, giving a total sample size of 15,247 eligible pregnancies
and 14,775 live births. Data were collected from self-report questionnaires, teacher report ques-
tionnaires, medical, educational and other records, birth registries, and hands on assessment.
Detailed information has been collected since birth via questionnaires and at annual clinics.
Ethical approval for the main study was obtained from the ALSPAC ethics and law committee
and the local research ethics committees, as described in detail previously.[28] Written
informed consent was provided by the parents and then from the young people when they
reached the age at which they were able to provide this. As this study purely related to analysis
of previously collected data, no specific ethical approval was required for this study.
APOEGenotyping
DNA samples were available in 2009 for 7091 children, 63% of the 11343 ALSPAC children
with potential DNA samples available. Genotyping of the young people for APOE was under-
taken by integrated single label liquid phase assay as described previously.[20] Full details of
this method have been published previously.[2]. PCR samples were analysed using a 384 well
LightTyper instrument (Roche diagnostics GmbH) and genotypes determined using LightTy-
per software, Ver 1. Samples were classified as ε2/2, ε 2/3, ε 3/3, ε 3/4, ε 4/4, ε 4/2 or unknown.
In total 95% of the available samples were genotyped. After exclusion of siblings and children
of known non-white ethnicity, 5,995 children had genotype data. There was no strong evidence
of a sex difference in genotype distribution or of a deviation from Hardy Weinberg Equilib-
rium. APOE genotypes were available for 2,099 participants with 2-back data available and
2085 with 3-back data available.
Measures
Working memory was assessed using a computerised version of the n-back task. During this
task a series of numbers (0–9) were presented on the screen. Participants were ask to respond
on each occasion whether the number was the same as that presented N numbers ago, or if it
was not. The numbers were presented in black on a white screen for 500ms, with 3000ms
allowed for participants to respond by pressing “1” for a target and “2” for a non-target stimu-
lus. Accuracy to targets and non-targets in the 2 and 3 back conditions was used as the primary
outcome. This method of analysis accounts for response bias i.e. differential responding by par-
ticipants to targets versus non-targets. For example, it would be easy for a participant to be
100% accurate to targets, if they selected targets on every trial and thus had an accuracy to
non-targets of 0%. By analysing both at the same time any such bias is taken into account.
Accuracy to target was defined as the proportion of targets that had been correctly indi-
cated. This is the equivalent of “hits” in previous literature. Accuracy therefore varied between
1 = perfect accuracy and 0 = no targets correctly indicated. Accuracy to non target was defined
as the proportion of “non-targets” that the participant correctly identified. In order to make
APOE andWorking Memory
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the data more readily interpretable we present accuracy as a percentage. The reaction times
were calculated as the median of all the individual reaction times in each of the levels (2 or 3
back) for target or non-target trials. Thus there were 2 different original variables available at
each level of the n-back: reaction time to target and reaction time to non target.
The data were collected from participants who attended the teen focus 4 clinic at approxi-
mately 18 years of age (mean 17.8 yrs, SD 0.456). Of the 5,217 participants who attended the
clinic 3987 performed the N-back, 2135 of whom had an APOE genotype available. Three hun-
dred and ninety one participants had missing data excluded on the 2-back and 341 on the
3-back as they gave no response to any item on the task. This resulted in a total of 1,927 indi-
viduals with useable 2-back data and an APOE genotype available and 1,907 individuals with
useable 3-back data and an APOE genotype available, as shown in S1 Fig.
Co-variates
Co-variates adjusted for included demographic variables such as sex, family home-ownership
status (coded as mortgaged/owned, private rental, subsidised rental or other) and maternal
education, which we expected to be associated with the outcome variable. These same variables
were used in the previous study by Wardle et al who found effects on performance in the n-
back. [29] In addition, as there has been some debate about whether APOE genotype influences
IQ which is strongly associated with n-back performance we adjusted for full-scale IQ.[29]
This was measured at age 8 using the 3rd edition of the WISC as described in detail by Wardle
et al. [29]. Other co-variates were chosen based on previous research, theory, or that they were
associated with APOE and outcome and therefore might be a confounder.
Low density lipoprotein (LDL) and whether the participant had ever had a serious head
injury were also included as co-variates. LDL is known to be affected in an allele dose depen-
dent manner by APOE genotype and ApoE plays a major role in neuronal repair by re-distrib-
uting lipids to regenerating axons.[1, 30, 31] However, there are other influences on LDL level
so it might act as a confounder as well as being on the causal pathway between APOE genotype
and cognitive function. For this reason we decided to perform adjustments with and without
LDL as a covariate. Cholesterol is important in cell membrane and myelin formation and, com-
pared to other organs, the brain has a high cholesterol content.[32] It is currently thought that
the major causal pathway between ε4 possession and cognitive dysfunction is due to protein
instability, neurotoxic fragment production, increased amyloid beta production (and decreased
clearance) and increased tau phosphorylation rather than being via LDL and cerebrovascular
disease.[33–36] It has been shown that outcome following head injury is worse for those with
an ε 4 allele and head injuries are known to affect a range of cognitive functions.[37, 38]
The variation of IQ and other co-variates with APOE genotype is shown in Table 1. There
was no evidence to support an association of any of the co-variates with APOE genotype. How-
ever, we included these variables as they would be expected to improve the overall fit of the
regression model and in aggregate could be confounding the relationship. We considered a
number of other co-variates including alcohol use and smoking but did not include them as
they did not have an association with APOE genotype and we had no theoretical basis for an
association with the outcome.
Analyses
Accuracy on the n-back task across the 2 and 3 back levels was the primary outcome. Statistical
power was estimated at 87% to detect a 3.5% difference in accuracy rates at the 2 and 3 back
levels, based on data from previous analyses.[29]
APOE andWorking Memory
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In all analyses we used multi-level regression using the stata command xtreg with individual
as a random effect. The ε 33 group, the most frequent genotype, was used as the reference group
throughout. Initially the 2 and 3 back levels were considered separately, as some individuals were
missing data from one n-back level only. For this analysis the data was re-shaped into long for-
mat according to target/non-target. This permitted the regression to model accuracy to target
and non-target simultaneously, rendering separate analysis of false alarms and discriminability
unnecessary. Multi-level regression has the advantage that it accounts for clustering in the data
within individuals. For each outcome variable at each level of difficulty the regression was per-
formed with APOE genotype as the only exposure variable to test the crude (i.e. unadjusted)
association and then a further regression was then performed with adjustment for all co-variates.
Finally we used a further multi-level regression to examine the effects of APOE genotype on
outcomes across the 2 and 3 back levels. To test for overall gene effect likelihood ratio testing
was performed on the models with and without the APOE variable. To test for a linear effect or
quadratic effect of APOE, genotype was included in separate regression models as a linear term
and as a quadratic term. These were again performed as both crude and adjusted analyses.
In the multi-level analysis individuals with missing or missing data at either the 2 or 3 back level
were excluded, which reduced the number available for analysis (n = 1834). Two hundred and eight
participants had missing data for the 2-back, 184 for the 3-back and 91 hadmissing data in both.
We primarily used APOE genotype as a categorical variable, This is because there is an
established literature to support alleles 2 and 4 being differently functional relative to 3. The
risk of Alzheimer’s disease, however, shows an allele dose effect for the 4 allele. For this reason
we decided that it was sensible to analyse the data as both a categorical variable and as a linear
term in order to look for allele dose effects. We performed the analysis with a quadratic term to
allow for non-linearity in the results. The relationship between APOE genotype and plasma
Table 1. Number (%) andmeans (standard deviations) for demographics1 and other co-variates by Genotype.
Variable 22 32 33 34 44 F test or X2
Gender Male Female 6 (35.29%)11
(64.71%)
157 (49.37%)161
(50.63%)
543 (44.69%)672
(55.48%)
263 (48.52%)279
(51.48%)
16 (37.21%)27
(62.79%)
X2 = 5.79,
p = 0.22
Full scale IQ age 8 (SD) 112.80 (10.66) 107.50 (15.68) 108.12 (15.94) 108.54 (16.49) 110.81 (15.38)
Mother’s highest educational
qualiﬁcationCSEVocationalO levelA
levelDegree
0 (0%)0 (0%)7
(46.67%)6
(40.00%)2
(13.33%)
38 (13.06%)21
(7.22%)100
(34.36%)76
(26.12%))56
(19.24%)
104 (9.29%)77
(6.88%)382
(34.14%)322
(28.78%)234
(20.91%)
36 (7.19%)36
(7.19%)163
(32.53%)150
(29.94%)116
(23.15%)
2 (5.41%)5
(13.51%)16
(43.24%)9
(24.32%)5
(13.51%)
X2 = 18.99,
p = 0.27
Home OwnershipMortgage/
ownedPrivate rentalSubsidised
rentalOther
15 (100%)0
(0%)0 (0%)0
(0%)
247 (85.47%)13
(4.50%)18
(6.23%)11
(3.81%)
997 (88.78%)41
(3.65%)60
(5.34%)25
(2.23%)
429 (85.12%)17
(3.37%)43
(8.53%)15
(2.98%)
31 (77.50%)1
(2.50%)5
(12.50%)3
(7.50%)
X2 = 17.70,
p = 0.13
LDL age 9 mmol/litre (SD) 1.46 (0.76) 1.92 (0.47) 2.35 (0.55) 2.50 (0.52) 2.86 (0.63) F = 65.19, p
<0.001
Ever unconscious following a head
injury
2 (11.76%) 23 (7.23%) 121 (9.96%) 50 (9.23%) 3 (6.98%) X2 = 2.63,
p = 0.62
Alcohol use frequencyNeverMonthly
or less2-4x a month>2x month
08 (50.00%)7
(43.75%)1
(6.25%)
1 (0.37%)65
(23.90%)139
(51.10%)67
(24.63%)
23 (2.32%)266
(26.87%)446
(45.05%)255
(25.76%)
13 (2.89%)115
(25.56%)212
(47.11%)110
(24.44%)
07 (17.07%)24
(58.54%)10
(24.39%)
X2 = 17.77,
p = 0.12
1Data shown is for all study participants who had an APOE genotype available and who completed the n-back testing session. Qualiﬁcations shown are
British. O levels and CSEs were taken aged 16, A levels are taken aged 18. CSEs were a lower level of qualiﬁcation than O levels, which were taken by
those not expected to pass O levels.
doi:10.1371/journal.pone.0135894.t001
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LDL cholesterol is linear[30], but the relationship between APOE and AD risk is not, as men-
tioned previously. For this reason we felt that it was important to include both terms in our
analyses. We chose to reduce the risk of type 1 errors by using one overall significance test to
test for any differences between the categories.
Results
Of the 2,135 participants who completed the n-back and had an APOE genotype available, 17
had the ε22 genotype, 318 had the ε32 genotype, 1,215 had the had the ε33 genotype, 542 had
the ε34 genotype and 43 had the had the ε44 genotype. There was no evidence of deviation
from Hardy-Weinberg equilibrium. The raw values for accuracy and reaction times adjusted
for target are shown in S1 Table.
Accuracy
The data had been previously examined byWardle et al who found that hits were normally dis-
tributed at the 2 and 3 back levels and that the 3-back was more difficult with lower accuracy at
the 3 back level.[29] Full scale IQ was associated with accuracy at both levels of difficulty. At the
2-back level the regression coefficient was 0.003 (95% CI = 0.00273, 0.00416, p< 0.0001). At
the 3-back level the regression coefficient was 0.003 (95% CI = 0.00248, 0.00374, p< 0.0001).
The participants were also slightly more intelligent than the general population (mean
IQ = 108.2, 95%CI = 107.5–108.9, one sample t-test against mean of 100 p value =<0.00001).
Accuracy was initially examined at the two difficulty levels separately, as shown in table 2.
There was no strong evidence to support an effect of APOE genotype in the unadjusted regres-
sion at either level. In the adjusted analysis (n = 1,099) at the 2-back level, the overall p value for
genotype supported there being an effect of genotype (p = 0.04), but there was no evidence to
support the effect being linear or quadratic. Negative effects were seen in both the ε 22 (coeffi-
cient = -5.89%, 95% CI -15.58, 3.81) and ε 44 group (coefficient = -8.35%, 95% CI -15.51, –1.19).
In the adjusted regression at the 3-back level (n = 1,104) there was no strong evidence of
any effect of genotype on accuracy. Although all genotype groups performed worse than the ε
33 group, there was weak evidence that this difference was greater in the ε 44 genotype group
as shown in Table 2. Again there was no evidence to support a linear or quadratic effect of
genotype.
When performing the multilevel regression across both levels the crude analysis did not
show any evidence to support an effect of APOE genotype. The adjusted model showed evi-
dence of a small decline in performance in several of the groups as shown in Table 3, including
the ε22, ε34 and ε44 groups. The overall p value for genotype supported there being an effect
of genotype (p = 0.0071), but there was no evidence to support a linear or quadratic association.
The small decline in performance in the ε34 group was not present in the multilevel model
where LDL was not included as a co-variate, but not including LDL had no effect on the rela-
tionships seen in the regressions at the separate levels. The overall variance explained by this
model was 21.3% suggesting that there are many other factors involved in n-back accuracy.
There was no evidence of an interaction between gender and APOE.
Reaction Times
The same analysis strategy was then applied to reaction times. As described by Wardle et al,
reaction times were slower at the 3-back level and slowed more for men than for women.[29]
As the data were not normally distributed at either n-back level log transformations were used
to permit parametric testing. There was weak evidence of an interaction between gender and
APOE, which persisted in the adjusted model.
APOE andWorking Memory
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Reaction time was also initially examined at the two difficulty levels separately, as shown in
table 4. In the adjusted regression at the 2-back level (n = 1099) there was statistical evidence
that APOE genotype was associated with reaction time. In particular some evidence for faster
reaction times was seen in the ε34 group (coefficient = -0.06, 95%CI -0.10, -0.01) and the ε32
group (coefficient = -0.05, 95%CI -0.11, 0.003). The overall p value for genotype supported
there being an effect of genotype (p = 0.001), but there was no evidence to support the effect
being linear or quadratic.
In the adjusted analysis (n = 1104) at the 3-back level, there was again statistical evidence
that APOE genotype was associated with reaction time, with evidence of faster reaction times
in all groups except ε22. The overall p value for genotype supported there being an effect of
genotype (p = 0.02), but there was no evidence to support the effect being linear or quadratic.
When the multi-level regression was performed, as shown in table 5, there was statistical
evidence that APOE genotype was associated with reaction time in both the 2back and 3 back
condition. Only the ε22 group performed worse (slower) than the ε 33 reference group.
Table 2. Regression coefficients from regressions at each level separately of overall Accuracy to target and non-target in the n-back in relation to
APOE genotype. The results shown are for the model adjusted for target, home ownership, mother's education, IQ, gender, head injury and LDL aged 9.
The ε33 genotype was used as the reference group.
APOE
Genotype
2-back 2-back Minus LDL 3-back 3-back minus LDL
Co-
efﬁcient
95% CI P
value
Co-
efﬁcient
95%CI P
value
Co-
efﬁcient
95% CI P
value
Co-
efﬁcient
95%CI P
value
ε22 -5.89 -15.58 to
3.81
-5.23 -14.76 to
4.29
-0.29 -9.14 to
8.55
-0.18 -8.85 to
8.50
ε32 1.00 -2.18 to
4.18
0.90 -1.65 to
3.46
-1.39 -0.04 to
0.02
-1.71 -3.98 to
0.56
ε33 0 0 0 0
ε34 0.42 -2.00 to
2.85
0.78 -1.26 to
2.83
-1.32 -3.44 to
0.79
-0.27 -2.04 to
1.51
ε44 -8.35 -15.51 to
-1.19
-7.10 -13.15 to
-1.03
-5.61 -11.35 to
0.67
-2.67 -7.97 to
2.63
Overall p value 0.04 0.04 0.25 0.48
Linear term
(overall effect)
-0.80 -2.31 to
0.72
0.31 -0.31 -1.53 to
0.91
0.62 -0.01 -0.02 to
-0.01
0.32 0.23 -0.84 to
1.30
0.67
Quadratic term -0.16 -0.40 to
0.07
0.18 -0.07 -0.26 to
0.12
0.47 -0.001 -0.003 to
0.001
0.20 0.02 -0.15 to
0.18
0.85
doi:10.1371/journal.pone.0135894.t002
Table 3. Regression coefficients frommulti-level regression of APOE genotype against overall accuracy in the n-back. Adjustments were target,
home-ownership, mother's education, IQ, gender, head injury and LDL aged 9. The ε33 genotype was used as the reference group. The coefficients reflect
the change in percentage accuracy.
APOE Genotype Crude Adjusted Adjusted minus LDL
Co-efﬁcient 95% CI P value Co-efﬁcient 95% CI P value Co-efﬁcient 95% CI P value
ε22 0.33 -7.14 to 7.79 - 4.30 -12.2 to 3.56 -3.98 -11.71 to 3.73
ε32 -0.21 -2.19 to 1.77 0.44 -2.12 to 2.99 0.27 -1.78 to 2.34
ε33 0 0 0
ε34 0.37 -1.24 to 1.97 -0.44 -2.37 to 1.48 0.36 -1.27 to 1.98
ε44 -4.21 -8.84 to 0.42 -7.58 -13.16 to -2.00 -5.42 -10.15 to 0.70
Overall p value 0.75 0.01 0.03
Linear term (overall effect) -0.10 -1.05 to 0.85 0.83 -0.01 -1.95 to 0.46 0.22 -0.25 -1.23 to 0.73 0.62
Quadratic term -0.03 -0.18 to 0.12 0.70 -0.002 -0.34 to 0.04 0.12 -0.06 -0.21 to 0.09 0.44
doi:10.1371/journal.pone.0135894.t003
APOE andWorking Memory
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However there was no evidence for a linear relationship. The ε34 group had faster reaction
times than ε33 (coefficient = -0.05, 95% CI –0.10, -0.01). This relationship was not affected by
including LDL as a co-variate. The overall variance explained by this model was 4.6% suggest-
ing that there are many other factors involved in n-back reaction times.
Discussion
We studied working memory using the n-back, which is a widely used test of working memory,
in a community based birth cohort. The n-back task mainly measures updating of working
memory and consequently also involves executive function. This study is much larger than pre-
vious studies of working memory and APOE and thus has greater power to detect an effect of
APOE genotype on working memory performance.
Table 4. Regression coefficients from regressions performed at each level separately of log reaction time in the n-back in relation to APOE geno-
type. The results shown are for the model adjusted for target. home ownership, mother's education, IQ, gender, head injury and LDL aged 9. The ε33 geno-
type was used as the reference group. The log of reaction time was used as the residuals were not normally distributed when linear regression was
performed using untransformed reaction time.
APOE
Genotype
2-back 2-back adjMinus LDL 3-back 3-back adj minus LDL
Co-
efﬁcient
95% CI P
value
Co-
efﬁcient
95%CI P
value
Co-
efﬁcient
95% CI P
value
Co-
efﬁcient
95%CI P
value
ε22 0.03 -0.14 to
0.21
0.05 -0.13 to
0.22
0.001 -0.22 to
0.22
0.01 -0.21 to
0.22
ε32 -0.05 -0.11 to
0.003
-0.06 -0.11 to
-0.02
-0.05 -0.12 to
0.02
-0.06 -0.12 to
-0.01
ε33 0 0 0 0
ε34 -0.06 -0.10 to
-0.01
-0.02 -0.06 to
0.02
-0.06 -0.11 to
-0.01
-0.02 -0.06 to
0.02
ε44 0.06 -0.07 to
0.19
0.06 -0.05 to
0.17
-0.06 -0.21 to
0.10
-0.04 -0.17 to
0.09
Overall p value 0.001 0.004 0.02 0.05
Linear term
(overall effect)
-0.01 -0.03 to
0.02
0.71 0.01 -0.007 to
0.04
0.19 -0.03 -0.06 to
0.01
0.11 0.01 -0.02 to
0.03
0.59
Quadratic term -0.001 -.005 to
0.003
0.70 0.002 -0.001 to
0.006
0.232 -0.005 -0.01 to
0.0004
0.07 0.001 -0.003 to
0.005
0.77
doi:10.1371/journal.pone.0135894.t004
Table 5. Regression coefficients frommulti-level regression of APOE genotype against log reaction time in the n-back with adjustment for home
ownership, mother's education, IQ, gender, head injury and LDL aged 9. The ε33 genotype was used as the reference group. The log of reaction time
was used as the residuals were not normally distributed when linear regression was performed using untransformed reaction time.
APOE Genotype Crude Adjusted Adjusted minus LDL
Co-
efﬁcient
95% CI P
value
Co-
efﬁcient
95% CI P
value
Co-
efﬁcient
95% CI P
value
ε22 0.03 -0.13 to 0.19 0.02 -0.16 to 0.19 0.02 -0.15 to 0.19
ε32 -0.04 -0.08 to 0.003 -0.04 -0.01 to 0.02 -0.05 -0.10 to -0.003
ε33 0 0 0
ε34 -0.01 -0.04 to 0.02 -0.05 -0.10 to -0.01 -0.02 -0.06 to 0.02
ε44 0.01 -0.09 to 0.11 -0.002 -0.13 to 0.12 0.0003 -0.10 to 0.11
Overall p value 0.17 0.0003 0.009
Linear term (overall
effect)
0.01 -0.01 to 0.03 0.44 -0.01 -0.04 to 0.13 0.30 0.01 -0.007 to 0.04 0.19
Quadratic term 0.001 -0.002 to
0.004
0.51 -0.003 -0.01 to
0.002
0.23 0.002 -0.001 to
0.005
0.28
doi:10.1371/journal.pone.0135894.t005
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Findings from our study
We found evidence to support reduced accuracy according to APOE genotype in the n-back at
the 2-back level, but not the 3-back level though the direction of association was similar for
3-back. The adjusted multi-level model found evidence for an association with genotype, with
worse performance in the ε22, ε 34 and ε44 groups. This supports our hypothesis that those
with ε4 alleles would perform worse on the working memory task. We do not have any strong
evidence to support an allele dose effect, but this may be due to the low numbers of ε44 homo-
zygotes (n = 43). The ε22 group is also very small which may go some way towards explaining
the worse performance in this group. The fact that the ε32 group did not perform worse
strongly suggests that this is the likeliest explanation.
Previous studies have reported that ε2 possession is associated with better cognitive perfor-
mance in old age, in contrast to our findings.[39, 40] Interestingly, neuropathological studies
have suggested that this protection declines in old age, particularly after the age of 80.[41, 42]
A recent fRMI study of middle aged adults found very similar activity patterns in the ε4+ and
ε2+ groups during stroop and encoding tasks, with both groups showing increased activity in
non-task related regions compared to the reference ε33 group. The authors commented that
many previous fMRI studies had failed to adequately examine ε2 carriers and that the relation-
ship between BOLD response and Alzheimer’s disease is probably not as simple as was first
thought, with detriments possibly to be found in ε2 carriers as well as ε4 carriers. They also
commented that the effects of APOE on functional connectivity needed further research.[43]
When reaction time was examined at each level separately there was evidence to support an
effect of APOE genotype at both levels, although the evidence was slightly weaker for the
3-back. The adjusted multi-level model found evidence for an association with genotype, with
faster reaction times in the ε32, ε34 and ε44 groups although only the ε34 group had a 95%
confidence interval for the regression coefficient that did not cross zero. There were some con-
flicting results when reaction time was examined, however, with the ε44 group being slower
than the reference group at the 3-back level, but faster at the 2-back level. It is notable that the
ε44 group were less accurate at the 2-back level but not the 3-back. Reaction time is known to
be a more variable measure than accuracy and it is because of this that accuracy is the usual pri-
mary outcome measure when assessing n-back performance. Because of the inconsistencies in
this analysis we are therefore less confident that there is a genuine effect of genotype.
Comparison with previous studies
In previous studies younger adults have been little studied, with most studies focusing on older
adults. Several different working memory tasks, assessing different aspects of working memory
have been used, making it difficult to compare study results. In one of two studies to include
younger adults Alexander and colleagues studied 415 participants aged 6–65 and performed
only the 1-back, finding no association of APOE genotype with working memory.[17] This
may simply be a reflection of the low level of difficulty of the 1-back task and the fact that it is
more of a measure of sustained attention. This study also had low numbers of ε44 (n = 13)
although there were 91 ε4 carriers in total. They controlled only for age and education. Rusted
and colleagues studied 41 young adults (aged 18–22 yrs) in a study which was primarily
focused on fMRI. There was weak evidence of superior accuracy for ε4 carriers in the RVIP.
Our study is therefore only one of two to study just young adults and is far larger than the
study by Rusted et al.[13]
In the study with the next youngest cohort Reinvang and colleagues studied 186 40–80 year
olds using the more difficult AX continuous performance task (participants had to detect a cer-
tain pair of letters). They found a deleterious effect of ε4 on working memory in male (but not
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female) ε44 homozygotes. [14] Given the low number of ε44 homozygotes and the subgroup
analysis this may be a type 1 error. They did not control for co-variates. Greenwood and col-
leagues studied 177 healthy older individuals (41–85) from the BIOCARD study using a spatial
working memory task. This study has robust methods but low numbers, did not control for
covariates and no formal power calculation was given. They found a deleterious effect only in
ε44 homozygotes (n = 12), particularly when the task required participants to remember 3
locations rather than 2.[15] Finally Deeny and colleagues studied 51 of older participants (50+)
with a non-standard measure of working memory (cognometer battery). They found an
adverse effect of ε4 on speed of processing in working memory tasks but not performance,
after controlling for age, gender and education. [44, 45] Given the small size of these previous
studies it seems entirely likely that low power and chance findings are a plausible explanation
for the inconsistent findings. Our study used a well-recognised measure of working memory,
was larger than the previous studies and did control for covariates
Positive pleiotropy
Although the ε3 allele is now the most common it is thought that ε4 is the ancestral allele in
humans. Interestingly other animals have only a single isoform of ApoE. It seems likely, given
that the ε4 allele has persisted in humans, that there may be some positive effects in addition to
its many deleterious effects. It may be, however, that because the deleterious effects mainly
manifest after reproductive age that no such positive effects exist.
It was first suggested in 2001 by Hubacek that the ε4 allele may have positive pleiotropic
effects. In a small study which randomly studied 1% of the population of a region in the Czech
Republic they found that those with the ε4 allele were more likely to have attended higher edu-
cation.[18] Later, larger studies have looked at IQ, educational attainment (e.g., SATS scores)
and relation to APOE genotype and have not found any relationship prior to old age.[20, 46,
47] However, some authors have used evidence from functional imaging studies to supports
the idea of positive pleiotropy in those with ε4 alleles.[23, 24] For example, Filippini et al found
using BOLD fMRI that ε4 carriers had increased hippocampal activation during an encoding
task but this could also be interpreted as a sign that more brain activation was required for a
similar performance.[24] The exact mechanism of this positive pleiotropy, should it genuinely
exist is unknown and no positive pleiotropic effects were seen in this study.
Study Strengths and Limitations
Strengths of this study include the large sample size, adjustment for co-variates, the use of a
more robust measure of working memory than some previous studies and the unselected
nature of the sample. Despite this, the number of participants with ε44 was still quite low.
Weaknesses include the lack of a 1-back as a measure of attention and the participants were
slightly more intelligent than the general population. However we adjusted for a number of fac-
tors including IQ and still found differences according to genotype in working memory perfor-
mance. This is a common problem in cohort studies where there is differential drop-out of
those with lower socio-economic class and educational attainment.[48]
Conclusions
In conclusion we have found evidence for a deleterious effect of ε44 APOE genotype on accu-
racy as a measure of working memory in a large birth cohort tested at age 18. This is consistent
with the hypothesis that ApoE can affect neuronal repair early in life, well before the onset of
the clinical signs and symptoms of dementia. It is possible that larger effects may be seen in
older cohorts, perhaps as a result of the role of APOE in neuronal repair and the cumulative
APOE andWorking Memory
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inefficiencies proposed in ε4 carriers. We found no evidence to support a positive pleiotropic
effect of ε4.
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